Skip to content

Cost-utility Analysis of the Use of a Laser Fiber in the Management of Non-abscessed Pilonidal Cyst

Cost-utility Analysis of the Use of a Laser Fiber in the Management of Non-abscessed Pilonidal Cyst

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07652099
Acronym
ACONIDAL
Enrollment
150
Registered
2026-06-16
Start date
2026-06-15
Completion date
2029-12-15
Last updated
2026-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-abscessed Pilonidal Cyst

Keywords

Pilonidal disease, Pilonidal sinus, Laser fiber, Conventional surgery, Cost-utility

Brief summary

This multicenter, prospective, randomized, open-label trial compares laser fiber treatment with conventional surgery in adults with non-abscessed pilonidal cyst. The main objective is to evaluate the incremental cost-utility ratio of laser fiber versus conventional surgery over 12 months from a societal perspective. Secondary objectives include 3-month cost-utility, healing time, closure at 3 months, recurrence at 12 months, postoperative complications, treatment parameters, postoperative pain, and duration of sick leave.

Detailed description

Pilonidal cyst surgery is common in France and mainly affects young adults. Conventional surgery is effective but may be associated with longer healing time, prolonged dressing use, and work absence. Laser fiber treatment is a minimally invasive alternative used in France since 2019 and may reduce healing time and postoperative burden; however, prospective randomized comparative medico-economic evidence is lacking. This national multicenter study randomizes adults with non-abscessed pilonidal cyst to laser fiber treatment or conventional surgery in a 1:1 ratio. The primary endpoint is the incremental cost-utility ratio over 12 months, using total costs and utility derived from EQ-5D-5L (QALY). Participants are followed from baseline to month 12, with assessments at J8, J15, M3, M6, M9, and M12.

Interventions

PROCEDURELaser fiber treatment

Use of a laser fiber introduced through the pilonidal cyst tract to destroy the cyst walls. Main steps include tract exploration, curettage, irrigation, two laser passes, and dry dressing.

PROCEDUREConventional surgery

Conventional surgical excision of the entire cystic area with packing and absorbent dressing.

Sponsors

Elsan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

1. Male or female aged 18 years or older and younger than 80 years. 2. Patient for whom excision of a non-abscessed pilonidal cyst by laser fiber or conventional surgery is indicated. 3. Patient informed and having provided free, informed, written consent before any study-specific procedure.

Exclusion criteria

1. Acute abscess. 2. Contraindication to surgery and/or anesthesia. 3. Need for urgent intervention for non-abscessed pilonidal cyst. 4. Participation in another ongoing study or exclusion period. 5. No health insurance coverage/protection. 6. Legal protection measure or deprived of liberty by judicial or administrative decision. 7. Hospitalized without consent.

Design outcomes

Primary

MeasureTime frameDescription
Incremental cost-utility ratio (ICUR) of laser fiber versus conventional surgery12 months after interventionCalculated from total 12-month costs (direct medical, direct non-medical, indirect costs, including recurrences) and utility gain derived from EQ-5D-5L / QALY.

Secondary

MeasureTime frameDescription
Incremental cost-utility ratio at 3 months3 months after intervention
Healing durationUp to 12 months after intervention
Closure of non-abscessed pilonidal cyst3 months after intervention
Recurrence of non-abscessed pilonidal cyst12 months after intervention
Postoperative complicationsShort term: intervention to day 15; medium term: day 15 to month 3; long term: month 6 to month 12
Treatment parametersAt day 0 interventionDuration of intervention and occupation time of operating room.
Postoperative pain evolutionBaseline to 12 months after intervention Pain measured at J0, J8, J15, M3, M6, M9, M12.Numeric Rating Scale with analgesic use taken into account.
Duration of sick leaveUp to 12 months after interventionDays from hospital discharge after treatment to return to work.

Countries

France

Contacts

CONTACTCharlène Py, Eng
charlene.py@elsan.care+33556003048

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026